In Brief
United States removes ad valorem tariffs on specific Indian speciality pharmaceutical products and active ingredients.
The United States has established a zero-tariff regime on selected speciality drugs and active pharmaceutical ingredients imported from India and 19 other nations.
The decision eliminates ad valorem tariffs—which are calculated as a fixed percentage of the monetary value of imported goods—lowering trade barriers for critical pharmaceutical exports.
Infra push and low base effect pushes core sector growth to series-high of 10.9% in October 2026
21 Nov 2026
We cut tax, but where are the hires, salary hikes: PM Modi to industry
20 Nov 2026
Govt proposes major CSR rule changes, seeks to include mental health, clean energy, PM internship scheme
20 Nov 2026
'India's challenge next year may be rupee's strength, not weakness': CEA Nageswaran
19 Nov 2026